• Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of "Buy" by Analysts

    Источник: Buzz FX / 28 ноя 2024 03:51:10   America/New_York


    Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Given Average Rating of "Buy" by Analysts Written by MarketBeat November 28, 2024 Share Link copied to clipboard. Shares of Day One Biopharmaceuticals, Inc.
    Read more...
Опубликовать